Trial intelligence / Profile preview

Zinc for Tinnitus in NIHL Patients

NCT02951715Completed

Sponsor
Chang Gung Memorial Hospital
Start
Dec 2013
Primary completion
Dec 2014
Modality
Orthosteric Ligands
01

Overview

Open-label, single-arm trial of zinc gluconate in tinnitus, sponsored by Chang Gung Memorial Hospital. Primary endpoints: Tinnitus Handicap Inventory at 2 months and Serum zinc level at 2 months. Started Dec 2013; status: completed.

02

Drugs

zinc gluconate
03

Conditions

tinnitus

Beyond the preview

Go deeper on NCT02951715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02951715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call